Am Fam Physician. 2024;110(1):online
Author disclosure: No relevant financial relationships.
DETAILS FOR THIS REVIEW
Study Population: 50 trials including 8,857 patients considered susceptible to recurrent urinary tract infections (UTIs)
Efficacy End Points: Number of participants with symptomatic, culture-verified UTIs
Harm End Points: Adverse events (e.g., gastrointestinal problems)
| Benefits of preventing UTI with cranberry products |
| 1 in 16 women with recurrent UTIs |
| 1 in 8 children |
| 1 in 9 people with susceptibility to UTI due to a bladder intervention |
| Harms of preventing UTI with cranberry products |
| No apparent difference in harms |
Narrative: UTIs affect more than 150 million individuals globally each year and impose a substantial financial burden on health care systems.1 The annual incidence of acute uncomplicated UTIs reaches 7% among women of all ages, and 30% of these women may experience a recurrence within 6 to 12 months.2,3
Already a member/subscriber?
Log In
Subscribe
From $165- Immediate, unlimited access to all AFP content
- More than 130 CME credits/year
- AAFP app access
- Print delivery available
Issue Access
$59.95- Immediate, unlimited access to this issue's content
- CME credits
- AAFP app access
- Print delivery available
Purchase Access:
Learn More
